OR WAIT 15 SECS
© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
September 29, 2020
To effectively lead in today’s unpredictable environment, several major pharma companies are turning to a neuroscience-based learning approach to leadership development.
September 20, 2020
Dr. George Westerman talks to Michael Wong about how smarter executives will successfully lead their workforces in a post COVID-19 business environment.
September 13, 2020
President Trump has taken on the pharma industry in a surprise move making significant cuts in reimbursement for drugs covered by Medicare.
September 11, 2020
ESG objectives are integral to long-term biopharma strategy.
Assessing COVID-19’s wide and varied impact on pharma and biotech business in the first half of the year, and how it shapes market prospects ahead.
September 08, 2020
Looking at four building blocks of success, Wolfram Lux and Simone Seiter investigate what it takes to win and be successful when commercializing an orphan drug
The recent merger of Teledoc and Livongo into a $38 billion titan proves that the market sees opportunity in health tech. Could it be an inflection point in our race towards a digital-first care model, or is this an experiment ahead of its time?
August 27, 2020
Michael Wong talks with Dr. Francesca Gino, Tandon Family Professor of Business Administration at the Harvard Business School, about the advantages of embracing a "rebel mindset."
August 19, 2020
While HCPs are turning away from in-person meetings with sales reps amidst the COVID-19 pandemic, there are still strategies for them to keep their pipelines full.
August 18, 2020
A look into the complex battle between pharmaceutical manufacturers and payers for balance between medication access and budget management.